Orthofix Medical Inc (OFIX)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $292.25M
Last updated: Nov 17, 2026 at 11:05 AM ET
Orthofix Medical Inc (OFIX) Valuation Multiples
Orthofix Medical (OFIX) trades at 0.3x sales and 0.7x book value. Its P/S of 0.3x is below its 5-year median of 0.7x. Its forward P/E is 500.0x.
Current Multiples
Its enterprise value is 11.2x its EBITDA.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 500.0x |
| Price to sales | 0.3x |
| Price to book | 0.7x |
| EV/EBITDA | 11.2x |
| PEG | N/A |
| FCF yield | -15.9% |
Historical Medians
Against its 10-year medians, its P/S is 78.6% below 1.4x and its P/B is 58.8% below 1.7x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | N/A | 61.3x | 39.5x |
| P/S | 0.3x | 0.7x | 1.4x |
| P/B | 0.7x | 1.1x | 1.7x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 24.6x in 2016 to 674.0x in 2023.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $15.16 | 28.2x | 0.7x | 1.3x |
| 2024 | $17.46 | 71.1x | 0.8x | 1.3x |
| 2023 | $13.48 | 674.0x | 0.7x | 0.8x |
| 2022 | $20.53 | 68.4x | 0.9x | 1.2x |
| 2021 | $31.09 | 36.2x | N/A | 1.8x |
| 2020 | $42.98 | 171.9x | 2.0x | 2.3x |
| 2019 | $46.18 | 31.4x | 1.9x | 2.7x |
| 2018 | $52.49 | 29.3x | 2.2x | 3.0x |
| 2017 | $54.70 | 33.6x | 2.3x | 3.5x |
| 2016 | $36.18 | 24.6x | 1.6x | 2.5x |
GNG Valuation
| GNG view | Fairly valued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About OFIX
What is OFIX's forward P/E ratio?
Orthofix Medical has a forward P/E ratio of 500.0x.
Is OFIX stock overvalued?
GNG's valuation label for OFIX is Fairly valued.
What is OFIX's price to sales ratio?
Orthofix Medical has a price to sales ratio of 0.3x.
What is Orthofix Medical's average P/E ratio over 5 years?
Orthofix Medical's median P/E over the last 5 years is 61.3x, from 55 month-end values through Oct 2026.
OFIX pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors